EVIDENCE LIBRARY
A dental sedation series counted sessions and several different midazolam regimens
An Italian series reported completion of 41 selected dental sessions, but its mixed regimens and small retrospective sample could not establish a benzodiazepine-specific success or complication rate.
An Italian series reported completion of 41 selected dental sessions, but its mixed regimens and small retrospective sample could not establish a benzodiazepine-specific success or complication rate.
The unit of observation was a session
The investigators combined a retrospective single-center series with a narrative literature review. The clinical dataset included 41 sedation-assisted dental sessions involving patients with disabilities or neurodevelopmental conditions and patients with severe dental phobia. It included both children and adults.
The count should be described as sessions, not automatically as 41 independent patients. Selected procedures performed under sedation also do not represent every person considered for sedation or referred directly to general anesthesia.
Midazolam was used in different combinations
The regimen table listed 14 sessions with midazolam alone and 18 with midazolam plus propofol. Smaller categories included midazolam with propofol and fentanyl, midazolam with ketamine, a propofol regimen without benzodiazepines, and other combinations.
The authors reported completion of planned procedures without major adverse events or conversion to general anesthesia. Those observations describe the selected series as a whole. They do not isolate the effect of midazolam from patient selection, co-administered drugs, staff experience, monitoring, and procedure characteristics.
Completion does not answer every safety question
A completed dental procedure is a useful outcome, but it is not identical to the absence of every transient respiratory event, prolonged recovery, or later complication. A small series with no major reported events cannot establish that the risk is zero. Nor can it reliably compare uncommon complications between regimens represented by only a few sessions.
The paper supports an individualized care pathway in which behavioral management, sedation, and general anesthesia have different roles. Its retrospective design, single-center setting, and heterogeneous regimens limit broader claims. For a case review, the relevant comparison is the actual patient, procedure, medication combination, monitoring, and documented course—not an assumed universal success rate for benzodiazepine sedation.
Source paper
Original analysis of the supplied journal article, identified as PMC13073206.